|
gptkb:T_regulatory_cells
|
autoimmune diseases
|
|
gptkb:Cdk4
|
gptkb:Ribociclib
|
|
gptkb:Human_serotonin_receptor_5-HT1B
|
antidepressants
|
|
gptkb:cholecystokinin_B_receptor
|
antipsychotic drugs
|
|
gptkb:platelet-derived_growth_factor_receptor_beta
|
gptkb:sunitinib
|
|
gptkb:cyclin_dependent_kinase_4
|
gptkb:abemaciclib
|
|
gptkb:SARS-CoV-2_main_protease
|
COVID-19 antiviral drugs
|
|
gptkb:VMAT2
|
antipsychotic drugs
|
|
gptkb:glycine_receptor
|
muscle relaxants
|
|
gptkb:P09056
|
gptkb:Osimertinib
|
|
gptkb:ALK_rearrangement
|
gptkb:crizotinib
|
|
gptkb:p97
|
CB-5083
|
|
gptkb:TNFRSF17
|
gptkb:belantamab_mafodotin
|
|
gptkb:Serotonin
|
gptkb:SSRIs
|
|
gptkb:IL5RA_gene
|
gptkb:mepolizumab
|
|
gptkb:proto-oncogene_c-RET
|
gptkb:vandetanib
|
|
gptkb:tumor_necrosis_factor_alpha
|
gptkb:etanercept
|
|
gptkb:chronic_myeloid_leukemia
|
gptkb:BCR-ABL_tyrosine_kinase
|
|
gptkb:VEGF_gene
|
gptkb:ranibizumab
|
|
gptkb:ERBB2_gene
|
gptkb:lapatinib
|